Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lee, Cheng-Han
Subramanian, Subbaya
Beck, Andrew H.
Espinosa, Inigo
Senz, Janine
Zhu, Shirley X.
Huntsman, David
van de Rijn, Matt
Gilks, C. Blake
and
Toland, Amanda Ewart
2009.
MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary.
PLoS ONE,
Vol. 4,
Issue. 10,
p.
e7314.
Lee, Chun-Feng
Ling, Zhi-Qiang
Zhao, Ting
Fang, Shih-Hua
Chang, Weng-Cheng
Lee, San-Chih
and
Lee, Kuan-Rong
2009.
Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma.
World Journal of Gastroenterology,
Vol. 15,
Issue. 3,
p.
356.
Gilks, C. Blake
and
Prat, Jaime
2009.
Ovarian carcinoma pathology and genetics: recent advances.
Human Pathology,
Vol. 40,
Issue. 9,
p.
1213.
McAlpine, Jessica N
Wiegand, Kimberly C
Vang, Russell
Ronnett, Brigitte M
Adamiak, Anna
Köbel, Martin
Kalloger, Steve E
Swenerton, Kenneth D
Huntsman, David G
Gilks, C Blake
and
Miller, Dianne M
2009.
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.
BMC Cancer,
Vol. 9,
Issue. 1,
Pradhan, Manohar
Risberg, Björn Å
Tropé, Claes G
van de Rijn, Matt
Gilks, C Blake
and
Lee, Cheng-Han
2010.
Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation.
BMC Cancer,
Vol. 10,
Issue. 1,
Köbel, Martin
Reuss, Alexander
Bois, Andreas du
Kommoss, Stefan
Kommoss, Friedrich
Gao, Dongxia
Kalloger, Steve E
Huntsman, David G
and
Gilks, C Blake
2010.
The biological and clinical value of p53 expression in pelvic high‐grade serous carcinomas.
The Journal of Pathology,
Vol. 222,
Issue. 2,
p.
191.
Xian, Wa
Miron, Alexander
Roh, Michael
Semmel, Dana R
Yassin, Yosuf
Garber, Judy
Oliva, Esther
Goodman, Annekathryn
Mehra, Karishma
Berkowitz, Ross S
Crum, Christopher P
and
Quade, Bradley J
2010.
The Li–Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube.
The Journal of Pathology,
Vol. 220,
Issue. 1,
p.
17.
Cooke, S L
Ng, C K Y
Melnyk, N
Garcia, M J
Hardcastle, T
Temple, J
Langdon, S
Huntsman, D
and
Brenton, J D
2010.
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.
Oncogene,
Vol. 29,
Issue. 35,
p.
4905.
Köbel, Martin
Kalloger, Steve E.
Baker, Patricia M.
Ewanowich, Carol A.
Arseneau, Jocelyne
Zherebitskiy, Viktor
Abdulkarim, Soran
Leung, Samuel
Duggan, Máire A.
Fontaine, Dan
Parker, Robin
Huntsman, David G.
and
Gilks, C. Blake
2010.
Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible.
American Journal of Surgical Pathology,
Vol. 34,
Issue. 7,
p.
984.
Crum, Christopher P.
and
Xian, Wa
2010.
Bringing the p53 signature into focus.
Cancer,
Vol. 116,
Issue. 22,
p.
5119.
Gilks, C. Blake
2010.
Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma.
Journal of Oncology,
Vol. 2010,
Issue. ,
p.
1.
Carey, Mark S.
Agarwal, Roshan
Gilks, Blake
Swenerton, Kenneth
Kalloger, Steve
Santos, Jennifer
Ju, Zhenlin
Lu, Yiling
Zhang, Fan
Coombes, Kevin R.
Miller, Dianne
Huntsman, David
Mills, Gordon B.
and
Hennessy, Bryan T.
2010.
Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy.
Clinical Cancer Research,
Vol. 16,
Issue. 10,
p.
2852.
Gilks, C. Blake
2011.
Diagnostic Pathology of Ovarian Tumors.
p.
55.
Jazaeri, Amir A.
Bryant, Jennifer L.
Park, Hong
Li, Hui
Dahiya, Neetu
Stoler, Mark H.
Ferriss, James Stuart
and
Dutta, Anindya
2011.
Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma.
Neoplasia,
Vol. 13,
Issue. 10,
p.
899.
McAlpine, J.N.
El Hallani, S.
Lam, S.F.
Kalloger, S.E.
Luk, M.
Huntsman, D.G.
MacAulay, C.
Gilks, C.B.
Miller, D.M.
and
Lane, P.M.
2011.
Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: A promising step towards screening and early detection.
Gynecologic Oncology,
Vol. 120,
Issue. 3,
p.
385.
Köbel, Martin
Turbin, Dmitry
Kalloger, Steve E.
Gao, Dongxia
Huntsman, David G.
and
Gilks, C. Blake
2011.
Biomarker Expression in Pelvic High-grade Serous Carcinoma.
International Journal of Gynecological Pathology,
Vol. 30,
Issue. 4,
p.
366.
Dobrzycka, B.
Terlikowski, S.J.
Kinalski, M.
Kowalczuk, O.
Niklinska, W.
and
Chyczewski, L.
2011.
Circulating free DNA and p53 antibodies in plasma of patients with ovarian epithelial cancers.
Annals of Oncology,
Vol. 22,
Issue. 5,
p.
1133.
Schlosshauer, Peter W.
Deligdisch, Liane
Penault-Llorca, Frédérique
Fatemi, Delaram
Qiao, Rui
Yao, Shen
Pearl, Meghan
Yang, Zhen
Sheng, Tao
and
Dong, Jianli
2011.
Loss of p16INK4A Expression in Low-grade Ovarian Serous Carcinomas.
International Journal of Gynecological Pathology,
Vol. 30,
Issue. 1,
p.
22.
Vereczkey, Ildikó
Serester, Orsolya
Dobos, Judit
Gallai, Mónika
Szakács, Orsolya
Szentirmay, Zoltán
and
Tóth, Erika
2011.
Molecular Characterization of 103 Ovarian Serous and Mucinous Tumors.
Pathology & Oncology Research,
Vol. 17,
Issue. 3,
p.
551.
Köbel, Martin
and
Huntsman, David
2011.
Molecular Pathology of Ovarian Carcinomas.
Surgical Pathology Clinics,
Vol. 4,
Issue. 1,
p.
275.